|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/24 | |
| C12N 15/13 | |||
| A61K 39/395 | |||
| A61P 35/00 | |||
| A61P 29/00 | |||
| A61P 19/02 | |||
| A61P 37/02 | |||
| G01N 33/68 | |||
| G01N 33/577 |
| (11) | Number of the document | 3178847 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15830493.1 |
| Date of filing the European patent application | 2015-03-18 | |
| (97) | Date of publication of the European application | 2017-06-14 |
| (45) | Date of publication and mention of the grant of the patent | 2021-03-03 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/CN2015/074528 |
| Date | 2015-03-18 |
| (87) | Number | WO 2016/019726 |
| Date | 2016-02-11 |
| (30) | Number | Date | Country code |
| 201410390493 | 2014-08-08 | CN |
| (72) |
SUN, Le, CN
ZHANG, Xiaogang, CN
LI, Maohua, CN
ZHANG, Cuijuan, CN
|
| (73) |
Abmax Biotechnology Co., Ltd,
99 Kechuang 14th Street Building 18, Unit 2, Suite 201 BDA, Beijing 101111,
CN
|
| (54) | ANTI-TNF-ALPHA FULLY HUMAN MONOCLONAL ANTIBODIES WITH LOW IMMUNOGENICITY AND APPLICATION THEREOF |
| ANTI-TNF-ALPHA FULLY HUMAN MONOCLONAL ANTIBODIES WITH LOW IMMUNOGENICITY AND APPLICATION THEREOF |